WSJ -- Novartis AG will try to muscle into a crowded market for over-the-counter heartburn drugs this week by launching its new pill, Prevacid 24HR, with the backing of the pharmaceutical giant’s largest-ever OTC ad campaign.
WSJ -- Novartis AG will try to muscle into a crowded market for over-the-counter heartburn drugs this week by launching its new pill, Prevacid 24HR, with the backing of the pharmaceutical giant’s largest-ever OTC ad campaign.
